5Z9-11150-87478
2 vaccinations
5 coded responses
22 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 223 / VA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-06
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Enlarged supraclavicular lymph node x2 on side of vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Enlarged supraclavicular nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Enlarged tender supraclavicular nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Enlarged tender supraclavicular nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Enlarged tender supraclavicular node - improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-04-14
- 2021-07-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Enlarged supraclavicular lymph node x2 on side of vaccine
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Enlarged supraclavicular node
Systemic reaction (other): Enlarged tender supraclavicular node
Systemic reaction (other): Enlarged tender supraclavicular node
Systemic reaction (other): Enlarged tender supraclavicular node - improving
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release